GSK is a global biopharma company with a purpose to unite science, technology and talent to get ahead of disease together. We aim to positively impact the health of 2.5 billion people over the next 10 years. Our bold ambitions for patients are reflected in new commitments to growth and a step-change in performance. We prioritize innovation in vaccines and specialty medicines, maximizing the increasing opportunities to prevent and treat disease. At the heart of this is our R&D focus on the science of the immune system, human genetics and advanced technologies, and our world-leading capabilities in vaccines – having the broadest vaccines portfolio in the industry - and medicines development. In Canada, GSK employs over 1,450 full time employees across the country. We are headquartered in Mississauga, Ontario, and have a regional business office in Montreal, Quebec, as well as a manufacturing facility and administrative office in Sainte-Foy, Quebec. Since 2001, GSK has invested more than $2 billion in vaccine and pharmaceutical R&D in Canada, including over $109 million in 2022 alone. GSK has invested more than $21 million in 54 active clinical trials across Canada, involving 3,700 subjects in 2022. LEARN MORE: Website: www.gsk.ca Twitter: @gskca LinkedIn: GSK